Researchers found data that showed that patients with hepatitis D virus did not benefit by combination therapy with tenofovir disoproxil fumarate and peginterferon alfa-2a, concluding that alternative therapies are needed.
Researchers found evidence in a genome-wide study that to prevent liver cancer among patients who have been treated for hepatitis C virus infection the sphingosine kinase 1 oncogene should be targeted.
Researchers conducted a case series to examine the demographics, presentation, management, and outcomes in patients with post-implant calcium pyrophosphate deposition disease.
Researchers conducted a post hoc analysis on antipneumococcal antibody responses in patients with SLE previously immunized with the 23-valent pneumococcal polysaccharide vaccine.
The use of macrolide adjunctive therapy has been shown to be safe and effective for the treatment of children with wheezing disease.
Researchers examined a full range of data on neurological complications in newborns and infants born to women infected with Zika virus.
Investigators evaluated the safety and effectiveness of conventional therapy with biologic immunosuppressive drugs to treat patients with HIV infection and psoriasis.
Investigators examined tolerability, effectiveness, and safety profile of topical antibacterial agent ozenoxacin in adults and children with impetigo.
Pneumococcal vaccination rates in patients with systemic lupus erythematosus improved significantly after the implementation of a multifaceted intervention at a rheumatology practice.
The widespread implementation of ALT-70 into clinical practice may help decrease misdiagnosis rates of lower-extremity cellulitis.
